Pharma Focus Asia

Frontage Laboratories Expands Bioanalytical Capacity and Capabilities

Frontage Laboratories is expanding its bioanalytical laboratories in the US, in Exton, P.A.

The expansion will include an additional 10,000 square feet of laboratory space to support biologic drug development, cell and gene therapy development as well as biomarker analysis.

Additionally, the expansion will establish a center of excellence for cell and gene therapies that will include dedicated labs in DNA separation, purification, flow cytometry, and cell culture.

The expansion will also provide greater biomarker, pharmacokinetic, and immunogenicity bioanalytical capability to support large phase II-IV studies.

Moreover, the support services are also being enhanced, including sample management and sample storage space, as part of the expansion.

The instrument capacity for liquid chromatography with tandem mass spectrometry and inductively coupled plasma mass spectrometry is also being expanded to support both large and small molecule as well as elemental analysis.

The expansion is scheduled for completion in the fourth quarter of 2019.

Specifications:

NameFrontage Laboratories
LocationUSA
TypeExpansion
ScheduleScheduled to be operational by Q4-2019
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024